Teva to settle opioid-related claims in Florida for $117 million | The Times of Israel
Teva to pay $523 mln to New York as it looks to move past opioid lawsuits | Reuters
Will Cost Control Help Teva (TEVA) Beat on Q2 Earnings?
Teva sells its only manufacturing plant in Russia
Teva Stock: Sales Miss As Obstacles Continue To Mount | Investor's Business Daily
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Teva's global cutback spree is done. Now, it's aiming to grow with Ajovy, Austedo | Fierce Pharma
Teva's Latest Deal Looks a Healthier Mouthful -- Heard on the Street - WSJ
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
Teva, workers sign accord on Jerusalem factory closure terms | The Times of Israel
Outdoor Voices Tevas Collection 2019 | POPSUGAR Fashion
BDS movement on Twitter: "Another reason to boycott Israeli pharmaceutical giant TEVA. 40 U.S. states have accused TEVA and other drug companies of fraud. News report: https://t.co/qvQIuFr2ml https://t.co/NVPJhPWD4m" / Twitter
Is 2019 The Trough For Teva, Or Will 2020 Continue To See Pressure? (NYSE: TEVA) | Seeking Alpha
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube
Teva Pharmaceuticals Recalls Acute Myeloid Leukemia Drug Over Particulate Matter Contamination - Top Class Actions
Anna Sui on Where to Wear Her New Teva Sandals For Spring '19 – Footwear News
Teva's Benign Opioid Settlement Isn't in the Bag Yet - WSJ
Wow, Tevas Got Cute - The New York Times
Teva Pharmaceuticals Q2 2019 earnings preview | AlphaStreet
Teva Pharmaceutical Reports a Step Back in 2019 | The Motley Fool
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say - The New York Times
The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO | Ctech
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Opioid manufacturer Teva Pharmaceuticals announces $523M settlement with New York state - JURIST - News
Investors sue Teva over $41B Actavis deal - Drug Delivery Business
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva delays 33% of Jerusalem layoffs until 2019 - Israel News - The Jerusalem Post
